Intraparenchymal rAAV1 - (mi)RNA HTT
VY-HTT01-1
Phase 1 gene_therapy terminated
Quick answer
Intraparenchymal rAAV1 - (mi)RNA HTT for Huntington Disease is a Phase 1 program (gene_therapy) at Voyager Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Voyager Therapeutics
- Indication
- Huntington Disease
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- terminated